- Home
- NBH vs SOPH Comparison
NBH vs SOPH Comparison
Compare NBH & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NBH | SOPH |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 301.2M | 462.3M |
| IPO Year | 2002 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NBH | SOPH |
|---|---|---|
| Price | $9.26 | $8.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 101.3K | ★ 624.7K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.09 |
| Revenue Next Year | N/A | $19.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.24 | $3.75 |
| 52 Week High | $10.72 | $8.98 |
Technical Indicators
Market Signals| Indicator | NBH | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 21.13 | 57.08 |
| Support Level | N/A | $4.63 |
| Resistance Level | $10.41 | $8.84 |
| Average True Range (ATR) | 0.17 | 0.40 |
| MACD | -0.04 | -0.04 |
| Stochastic Oscillator | 1.20 | 68.38 |
Price Performance
Historical ComparisonAbout NBH Neuberger Berman Municipal Fund Inc.
Neuberger Berman Municipal Fund Inc is a closed-end management investment company that invests mainly in municipal securities. The company aims to provide common stockholders a high level of current income exempt from Federal income tax.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.